IN BOTH randomized double-blind and nonrandomized studies, our group and others have tested hydrazine sulfate in advanced-stage cancer patients and found it to have little value.1-4 If our clinical impressions are true, why does publicity engendered by Penthouse magazine, Gold,5 and Russian reports6-8 as to hydrazine's value contradict our experience?
I first heard of hydrazine from Joseph Gold, MD, of the Syracuse Cancer Research Institute in the spring of 1973. To his credit, the use of hydrazine was based on his original concept that the glycolysis of cancer cells and the presence of cancer stimulated gluconeogenesis, which constituted a systemic metabolic circuit capable of drawing substantial amounts of energy from the cancer host.9-10 Dr Gold postulated that this mechanism of energy loss was responsible for cancer cachexia, which he believed could be reversed by metabolically interrupting gluconeogenesis. Based on Gold's11,12 concept that he could reverse
Regelson W. The 'Grand Conspiracy' Against the Cancer Cure. JAMA. 1980;243(4):337–339. doi:10.1001/jama.1980.03300300015016
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.